- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 13, 2025
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Articles from the Rhode Island Current and Pharmaceutical Technology referenced a commentary published in the March 2025 issue of Population Health, Equity & Outcomes, the sister journal of The American Journal of Managed Care® (AJMC®) The article, “Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage,” argued that the stimulant shortage is due to executive functioning deficits not being included in diagnostic criteria, leading to an overdiagnosis of attention-deficit/hyperactivity disorder (ADHD).
An article from Fierce Healthcare referenced an article published on AJMC.com, the website of AJMC. The article, “How Insurance Claim Denials Harm Patients’ Health, Finances,” covered how delays in receiving medication can increase costs, worsen symptoms, and add stress on patients who need the essential medication as soon as possible. They also noted that claim denials have increased in the US by 16% from 2018 to 2024, exacerbating this issue.
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
5 Things Everyone Should Know for National Immunization Awareness Month
August 1st 2025National Immunization Awareness Month highlights the importance of lifelong vaccination to prevent diseases, a practice that has averted millions of deaths, proven to be a cost-effective public health strategy, and offers crucial protection even to individuals who are immunocompromised.
Read More
